| Description | Fasinumab (Anti-Human NGF), a human IgG1κ monoclonal antibody targeting nerve growth factor (NGF), has applications in clinical studies for acute sciatica and knee osteoarthritis (OA) [1]. |
| molecular weight | N/A |
| CAS | 1190239-42-9 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |